French pharmaceutical giant Sanofi-Aventis says its multiple sclerosis drug teriflunomide significantly cut relapses in patients who took the once-daily oral treatment.
Continue reading Sanofi Says MS Drug Reduces Relapses
Sanofi Says MS Drug Reduces Relapses originally appeared on DailyFinance on Fri, 15 Oct 2010 12:20:00.
Filed Under: Company News, Health Care, Genzyme Corporation , Sanofi Aventis, Stocks in the News